EZElisa™肿瘤坏死因子配体超家族成员12（TNFSF1
2）试剂盒-EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit- 询价
- Biogradetech
- 美国
- A-QEK01370-96wells
- 2025年07月12日
企业认证
相关产品推荐更多 >
Natalizumab ELISA试剂盒-Natalizumab ELISA Kit
询价
EZElisa™ Sorting Nexin 19（SNX19）ELISA试剂盒-EZElisa™ Sorting Nexin 19 (SNX19) ELISA Kit
询价
EZElisa™ ETS易位变体6（ETV6）试剂盒-EZElisa™ ETS translocation variant 6 (ETV6) Kit
询价
EZElisa™小鼠神经丝蛋白3（NEF3）ELISA试剂盒-EZElisa™ Mouse Neurofilament 3 (NEF3) ELISA Kit
询价
EZElisa™人游离λ轻链ELISA试剂盒-EZElisa™ Human Free Lambda Light Chain ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™肿瘤坏死因子配体超家族成员12（TNFSF12）试剂盒，EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit，肿瘤坏死因子配体超家族成员12（TNFSF12）试剂盒, Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit
产品名称：EZElisa™肿瘤坏死因子受体超家族成员8（TNFRSF8）试剂盒-EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit
产品货号：A-QEK01370-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：15.6 - 1,000 pg/ml
该EZElisa™肿瘤坏死因子配体超家族成员12（TNFSF12）试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™肿瘤坏死因子受体超家族成员8（TNFRSF8）试剂盒-EZElisa™ Tumor Necrosis Factor Ligand Superfamily, Member 12 (TNFSF12) Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Typing of Tumor Necrosis Factor Alleles
The tumor necrosis factor (TNF) locus contains the three closely related cytokine genes: TNF , and lymphotoxin α and �. The gene cluster lies at the telomeric end of the class III region of the major histocompatibility complex (MHC
Tumor Necrosis Factor as a Pharmacological Target
Tumor necrosis factor (TNF) was originally described as a molecule with antitumor properties released by macrophages stimulated with bacterial products. Almost at the same time that TNF was cloned, it was found to be identical to cachectin
Assay of Soluble Tumor Necrosis Factor Receptors
Over the last decade, numerous basic biological as well as experimental and clinical studies have firmly established the significance of tumor necrosis factor (TNF) as a principal proximal mediator of sepsis (1 –
技术资料暂无技术资料 索取技术资料
